Embecta Corp. last reported quarterly results on Aug 7, 2026, for Q3 FY2026 (the quarter ended Jun 30, 2026): revenue of $271.7 million (-8.1% year over year) and diluted EPS of $0.36. It usually reports 35–56 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 24, 2026.
Results for Q4 FY2026, the quarter ending around Sep 30, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Nov 25, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 35–56 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 7, 2026
38 days after quarter end
|
Q3 FY2026
ended Jun 30, 2026
|
272
-8.1%
|
21
-53.6%
|
0.36
-53.8%
|
|
May 5, 2026
35 days after quarter end
|
Q2 FY2026
ended Mar 31, 2026
|
222
-14.4%
|
-4
-117.4%
|
-0.07
-117.5%
|
|
Feb 5, 2026
36 days after quarter end
|
Q1 FY2026
ended Dec 31, 2025
|
261
-0.3%
|
44
|
0.74
|
|
Nov 25, 2025
56 days after quarter end
|
Q4 FY2025
ended Sep 30, 2025
|
264
-7.7%
|
26
+80.8%
|
0.44
+78.9%
|
|
Aug 8, 2025
39 days after quarter end
|
Q3 FY2025
ended Jun 30, 2025
|
296
+8.4%
|
46
+209.5%
|
0.78
+212.0%
|
|
May 9, 2025
39 days after quarter end
|
Q2 FY2025
ended Mar 31, 2025
|
259
-9.8%
|
24
-18.7%
|
0.40
-20.0%
|
|
Feb 6, 2025
37 days after quarter end
|
Q1 FY2025
ended Dec 31, 2024
|
262
-5.6%
|
0
-100.0%
|
0.00
-100.0%
|
|
Nov 26, 2024
57 days after quarter end
|
Q4 FY2024
ended Sep 30, 2024
|
286
+1.5%
|
15
+143.3%
|
0.25
+139.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- EMBC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1872789
- Former names
- Berra Newco, Inc. (until Sep 3, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.